If you are having trouble viewing this email, please view it on our website.

In recent years, clinical trials have significantly increased in length, cost and complexity. One of the main contributions to this is unnecessary trial procedures that aren’t associated with the study’s primary or secondary objectives or endpoints. “Clearing out the Clutter” summarizes the results of a recent Medidata-sponsored study conducted by the Tufts Center for the Study of Drug Development on clinical trial design and complexity. Download your complimentary copy now to learn more about the research findings, as well as ways that you can avoid common pitfalls in study design and protocol development so that only valuable procedures are included in your studies. Already subscribed to Medidata Solutions Worldwide? Unsubscribe from Medidata email communications?

79 Fifth Avenue, 8th Floor, New York, NY  10003. Already subscribed to Medidata Solutions Worldwide? Unsubscribe from Medidata email communications. ACT is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830. This is an advertisement sent on behalf of this advertiser.